(19)
(11) EP 1 439 796 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
02.06.2010 Bulletin 2010/22

(45) Mention of the grant of the patent:
07.04.2010 Bulletin 2010/14

(21) Application number: 02785288.8

(22) Date of filing: 23.10.2002
(51) International Patent Classification (IPC): 
A61F 2/00(2006.01)
(86) International application number:
PCT/EP2002/011860
(87) International publication number:
WO 2003/037215 (08.05.2003 Gazette 2003/19)

(54)

AREAL IMPLANT

FLÄCHIGES IMPLANTAT

IMPLANT AREOLAIRE

(84) Designated Contracting States:
ES FR GB IT

(30) Priority: 29.10.2001 DE 10153334

(43) Date of publication of application:
28.07.2004 Bulletin 2004/31

(73) Proprietor: Johnson & Johnson Medical GmbH
22851 Norderstedt (DE)

(72) Inventors:
  • UGAHARY, Franz
    NL-4002 WP Tiel (NL)
  • SCHULDT-Hempe, Barbara
    24576 Bad Bramstedt (DE)
  • PRIEWE, Jörg
    D-24114 Kiel (US)
  • WALTHER, Christoph
    24568 Kattendorf (DE)

(74) Representative: UEXKÜLL & STOLBERG 
Patentanwälte Beselerstraße 4
22607 Hamburg
22607 Hamburg (DE)


(56) References cited: : 
WO-A-01/54589
WO-A-02/07648
US-A- 5 122 155
 WO-A-01/56499
DE-A- 19 832 634
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).